Add to ORKGIn recent years, a large volume of medical and public health literature has been dedicated to the sexually transmitted infection Human Papillomavirus (HPV). The purpose of this paper is to provide a comprehensive assessment of recent empirical investigations which assess the public health impact of HPV and recent HPV vaccinations
Human papillomavirus (HPV) is the most common sexually transmitted disease, yet little is known abou...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Human Papillomavirus infections (HPV) are the most common sexually transmitted diseases in the Unite...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women an...
Human papillomavirus (HPV) is a common sexually transmitted infection that potentiates cancer in bot...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
Human papillomavirus (HPV) infections are responsible for 34,000 cancers per year throughout the Uni...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Human Papillomavirus (HPV) is the most common sexually transmitted disease worldwide (CDC, 2017). A ...
Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women an...
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemen...
The human papillomavirus (HPV) is a prevalent virus and the most common sexually transmitted infecti...
Human papillomavirus (HPV) is the most common sexually transmitted disease, yet little is known abou...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Human Papillomavirus infections (HPV) are the most common sexually transmitted diseases in the Unite...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women an...
Human papillomavirus (HPV) is a common sexually transmitted infection that potentiates cancer in bot...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
Human papillomavirus (HPV) infections are responsible for 34,000 cancers per year throughout the Uni...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Human Papillomavirus (HPV) is the most common sexually transmitted disease worldwide (CDC, 2017). A ...
Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women an...
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemen...
The human papillomavirus (HPV) is a prevalent virus and the most common sexually transmitted infecti...
Human papillomavirus (HPV) is the most common sexually transmitted disease, yet little is known abou...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...